P&G Health Names Shashank Srowthy as CFO, Effective October 1

Procter & Gamble Health has announced the appointment of Shashank Srowthy as its new Chief Financial Officer (CFO), effective October 1, 2025. This leadership transition follows the resignation of Lokesh Chandak, who will take up a new assignment as Senior Director – Finance & Accounting, Feminine Care for Asia Pacific, Middle East, and Africa at P&G.

About Shashank Srowthy

Education

• Bachelor’s in Electronics & Telecommunication Engineering, Pune University
• Master of Management Studies, JBIMS Mumbai

Experience

• Joined P&G in 2011
• Served in key finance roles across India, Dubai, and Singapore
• Known for driving strategic financial outcomes in diverse markets

Board and Regulatory Details

Srowthy will serve as an Additional Director until the upcoming Annual General Meeting. His appointment as Executive Director is subject to,

• Shareholders’ approval
• Central Government clearance under Section 196 of Companies Act, 2013

Significance of the Move

This leadership change reinforces P&G Health’s strategic focus on,

• Global finance expertise
• Operational agility across high-growth markets
• Strengthening financial oversight in the healthcare sector

Key Facts

• Company: Procter & Gamble Health
• New CFO: Shashank Srowthy
• Effective Date: October 1, 2025
• Predecessor: Lokesh Chandak
• Relevant Law: Section 196, Companies Act, 2013